{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:57:23Z","timestamp":1771045043421,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["21\/2551-0001959-0"],"award-info":[{"award-number":["21\/2551-0001959-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.actatropica.2025.107569","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T16:13:37Z","timestamp":1740413617000},"page":"107569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of the immunogenic potential of recombinant Mycobacterium bovis BCG expressing the ASP-2 and TC24 proteins from Trypanosoma cruzi"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1421-3475","authenticated-orcid":false,"given":"Guilherme","family":"Senna dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara da Rocha","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Severo Sabedra","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Kommling","family":"Seixas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibele","family":"Borsuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2025.107569_bib0001","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3389\/fimmu.2018.01929","article-title":"The unsolved jigsaw puzzle of the immune response in Chagas disease","volume":"9","author":"Acevedo","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0002","series-title":"Inflammation and Cancer, Methods in Molecular Biology","first-page":"107","article-title":"Approaches to determine expression of inflammatory Cytokines","author":"Amsen","year":"2009"},{"key":"10.1016\/j.actatropica.2025.107569_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1380049","article-title":"Mycobacterium bovis BCG as immunostimulating agent prevents the severe form of chronic experimental Chagas disease","volume":"15","author":"Arce-Fonseca","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0004","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1111\/eva.13068","article-title":"Extent of polymorphism and selection pressure on the Trypanosoma cruzi vaccine candidate antigen Tc24","volume":"13","author":"Arnal","year":"2020","journal-title":"Evol. Appl."},{"key":"10.1016\/j.actatropica.2025.107569_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007413","article-title":"A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection","volume":"13","author":"Barry","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107569_bib0006","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1016\/j.vaccine.2009.08.044","article-title":"Recombinant mycobacterium bovis BCG","volume":"27","author":"Bastos","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107569_bib0007","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.2569","article-title":"Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR\u03b3t and Ahr that leads to IL-17 production by activated B cells","volume":"14","author":"Bermejo","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0008","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.13469","article-title":"Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection","volume":"201","author":"Bontempi","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005902","article-title":"Th17 cells are more protective than Th1 cells against the intracellular parasite trypanosoma cruzi","volume":"12","author":"Cai","year":"2016","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.actatropica.2025.107569_bib0010","unstructured":"Centers for Disease Control and Prevention of the U.S., 2021. American trypanosomiasis. URL https:\/\/www.cdc.gov\/dpdx\/trypanosomiasisamerican\/index.html (accessed 8.15.24)."},{"key":"10.1016\/j.actatropica.2025.107569_bib0011","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","article-title":"A review of the BCG vaccine and other approaches toward tuberculosis eradication","volume":"17","author":"Cho","year":"2021","journal-title":"Hum. Vaccines Immunother"},{"key":"10.1016\/j.actatropica.2025.107569_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112848","article-title":"A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis","volume":"9","author":"Costa","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2025.107569_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cytogfr.2021.10.001","article-title":"Chagas disease: immunology of the disease at a glance","volume":"62","author":"Cristov\u00e3o-Silva","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.actatropica.2025.107569_bib0014","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/tropicalmed8070360","article-title":"What do you need to know before studying chagas disease? a beginner's guide","volume":"8","author":"De Fuentes-Vicente","year":"2023","journal-title":"Trop. Med. Infect. Dis"},{"key":"10.1016\/j.actatropica.2025.107569_bib0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2958.1993.tb00970.x","article-title":"Construction and use of integrative vectors to express foreign genes in mycobacteria","volume":"10","author":"Dellagostin","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0016","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2004.08.039","article-title":"Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines","volume":"23","author":"Dennehy","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107569_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/IAI.72.1.46-53.2004","article-title":"Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in Mice","volume":"72","author":"Dumonteil","year":"2004","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.actatropica.2025.107569_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008932","article-title":"Genetic diversity of Trypanosoma cruzi parasites infecting dogs in southern Louisiana sheds light on parasite transmission cycles and serological diagnostic performance","volume":"14","author":"Dumonteil","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107569_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.521409","article-title":"A specific IL6 polymorphic genotype modulates the risk of trypanosoma cruzi parasitemia While IL18, IL17A, and IL1B variant profiles and HIV infection protect against cardiomyopathy in Chagas disease","volume":"11","author":"Gomes Dos Santos","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0019","doi-asserted-by":"crossref","first-page":"e1630","DOI":"10.1371\/journal.pntd.0001630","article-title":"Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas\u2019 disease","volume":"6","author":"Guedes","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107569_bib0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14760584.2018.1534588","article-title":"Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned","volume":"17","author":"Kilpel\u00e4inen","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2025.107569_bib0021","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/blood.V89.11.4112","article-title":"Regulation of interleukin-10 gene expression: possible mechanisms accounting for its upregulation and for maturational differences in its expression by blood mononuclear cells","volume":"89","author":"Le","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.actatropica.2025.107569_bib0022","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/j.vaccine.2018.05.049","article-title":"Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain","volume":"36","author":"Leal","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107569_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin. Vaccine Immunol"},{"key":"10.1016\/j.actatropica.2025.107569_bib0024","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/pathogens12020282","article-title":"A review on the immunological response against trypanosoma cruzi","volume":"12","author":"Macaluso","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2025.107569_bib0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/infdis\/jis724","article-title":"High Interleukin 17 Expression Is Correlated With Better Cardiac Function in Human Chagas Disease","volume":"207","author":"Magalh\u00e3es","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2025.107569_bib0026","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/vaccines10040587","article-title":"Vaccine design against chagas disease focused on the use of nucleic acids","volume":"10","author":"Maldonado","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2025.107569_bib0027","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1016\/j.vaccine.2015.07.017","article-title":"Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice","volume":"33","author":"Martinez-Campos","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107569_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005300","article-title":"Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi","volume":"11","author":"Matos","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2025.107569_bib0029","doi-asserted-by":"crossref","first-page":"e59347","DOI":"10.1371\/journal.pone.0059347","article-title":"Recombinant yellow fever viruses elicit CD8+ T Cell responses and protective immunity against trypanosoma cruzi","volume":"8","author":"Nogueira","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actatropica.2025.107569_bib0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.vaccine.2018.12.050","article-title":"Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against leptospirosis","volume":"37","author":"Oliveira","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2025.107569_bib0031","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/prot.26537","article-title":"The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens","volume":"91","author":"Pacini","year":"2023","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.actatropica.2025.107569_bib0032","doi-asserted-by":"crossref","first-page":"R581","DOI":"10.1016\/j.cub.2005.07.049","article-title":"The inflammasome","volume":"15","author":"Petrilli","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0033","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/JLB.3A0318-111RR","article-title":"IL-10 participates in the expansion and functional activation of CD8+ T cells during acute infection with Trypanosoma cruzi","volume":"105","author":"Pino-Mart\u00ednez","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0034","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/life11060534","article-title":"Mechanisms associated with trypanosoma cruzi host target cell adhesion, recognition and internalization","volume":"11","author":"Rodr\u00edguez-Bejarano","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.actatropica.2025.107569_bib0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4049\/jimmunol.1003845","article-title":"IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection","volume":"188","author":"Roff\u00ea","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1574-695X.2007.00251.x","article-title":"Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice","volume":"50","author":"Sanchez-Burgos","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00626","article-title":"IL-6 Improves the nitric oxide-induced cytotoxic CD8+ T Cell dysfunction in human Chagas disease","volume":"7","author":"Sanmarco","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0038","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/21645515.2016.1242540","article-title":"Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human Chagas disease","volume":"13","author":"Seid","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.actatropica.2025.107569_bib0039","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00142-08","article-title":"Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas\u2019 disease","volume":"15","author":"Silveira","year":"2008","journal-title":"Clin. Vaccine Immunol"},{"key":"10.1016\/j.actatropica.2025.107569_bib0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9440(10)61741-5","article-title":"Modulation of chagasic cardiomyopathy by interleukin-4","volume":"159","author":"Soares","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172833","article-title":"The role of interleukin 17-mediated immune response in Chagas disease: high level is correlated with better left ventricular function","volume":"12","author":"Sousa","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.actatropica.2025.107569_bib0042","series-title":"Clinical Tuberculosis","first-page":"217","article-title":"BCG and other vaccines","author":"Tanner","year":"2020"},{"key":"10.1016\/j.actatropica.2025.107569_bib0043","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"37","author":"Tarleton","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.actatropica.2025.107569_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006240","article-title":"Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico","volume":"12","author":"Villanueva-Lizama","year":"2018","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X25000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:39:01Z","timestamp":1743143941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X25000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":45,"alternative-id":["S0001706X25000476"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107569","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the immunogenic potential of recombinant Mycobacterium bovis BCG expressing the ASP-2 and TC24 proteins from Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2025.107569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107569"}}